-
June 1, 2002PREVIEW
Targeted therapy for oncoogic diseases, chemoprevention of recurrent breast cancer, and other new ideas in cancer therapy were among the highlights when more than 25,000 oncology professionals...
-
March 1, 2002PREVIEW
Pegfilgrastim (Neulasta—Amgen) has been approved to decrease the incidence of infection, as manifested by febrile neutropenia, in patients receiving chemotherapy. While it carries nearly the...
-
January 1, 2002PREVIEW
Two new studies of small-cell and non–small-cell lung cancers reflect the sometimes real but quite limited progress medical researchers are making in increasing the effectiveness of chemotherapy...
-
November 1, 2001PREVIEW
Patients with low-grade and transformed low-grade non-Hodgkin’s lymphoma (LG NHL) have historically had poor prognoses, but that situation may soon improve. Under review at FDA are a pair of...
-
October 1, 2001PREVIEW
In addition to its already-proven effectiveness in treating hypercalcemia of malignancy (HCM), pamidronate (Aredia—Novartis) has now been shown to be efficacious in preventing bone loss during...
Pages

Medication Monitor
RSSFollow Medication Monitor on TwitterFollow APhA Druginfoline on Twitter


